New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
10:00 EDTYUM, RPRX, MPLX, INFI, BRFS, WAIR, RLGY, LNCO, CELG, BEAV, THLD, PXD, LINE, BIIBOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: BE Aerospace (BEAV) initiated with an Outperform at Imperial Capital... BRF Brasil Foods (BRFS) initiated with a Buy at Citigroup... Biogen (BIIB) initiated with a Buy at Brean Capital... Celgene (CELG) initiated with a Buy at Brean Capital... Infinity Pharmaceuticals (INFI) initiated with an Outperform at RBC Capital... LINN Energy (LINE) initiated with a Neutral at Goldman... LINN Energy (LINE) initiated with an Outperform at RW Baird... LinnCo (LNCO) initiated with a Buy at UBS... LinnCo (LNCO) initiated with a Neutral at Credit Suisse... MPLX (MPLX) initiated with a Buy at Citigroup... Matrix Service (MTRX) initiated with a Buy at DA Davidson... Pioneer Natural (PXD) initiated with a Buy at Citigroup... Realogy (RLGY) initiated with a Neutral at Citigroup... Repros Therapeutics (RPRX) initiated with a Buy at Roth Capital... Threshold Pharmaceuticals (THLD) initiated with a Buy at Brean Capital... Wesco Aircraft (WAIR) initiated with an In-Line at Imperial Capital... Yum! Brands (YUM) initiated with an Outperform at Macquarie
News For BEAV;BRFS;BIIB;CELG;INFI;LINE;LNCO;MPLX;PXD;RLGY;RPRX;THLD;WAIR;YUM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 20, 2015
07:32 EDTBIIBBiogen says new data supports Tecfidera as long-term treatment for MS patients
Subscribe for More Information
07:18 EDTBIIBAmerican Academy of Neurology to hold annual meeting
Subscribe for More Information
April 18, 2015
20:31 EDTTHLDThreshold Pharmaceuticals to hold analyst and investor day
Subscribe for More Information
April 17, 2015
10:00 EDTPXDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:58 EDTPXD, PXDPioneer Natural downgraded to Underperform from Outperform at CLSA
April 15, 2015
17:08 EDTCELGCelgene announces phase 2 Apremilast data
Subscribe for More Information
16:02 EDTRPRXRepros Therapeutics announces Nov. 30, PDUFA goal date for NDA
Subscribe for More Information
10:19 EDTLNCOOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTYUMOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:14 EDTBIIBBiogen volatility flat into new drug data
Biogen overall option implied volatility of 35 compares to its 26-week average of 34 according to Track Data, suggesting non-directional into results as shares rally in the preopen on Phase 2 RENEW study of anti-LINGO-1 in acute optic neuritis clinical data.
06:09 EDTYUMYum! Brands implied volatility of 30 at upper end of index
06:04 EDTYUMYum! Brands initiated with a Market Perform at Cowen
Target $81.
April 14, 2015
18:30 EDTBIIBOn The Fly: After Hours Movers
Subscribe for More Information
16:12 EDTBIIBBiogen presents new Anti-LINGO-1 Phase 2 AON data
Subscribe for More Information
11:25 EDTBIIBPTAB declares interference between Forward Pharma and Biogen regarding treatment
Subscribe for More Information
08:05 EDTINFIInfinity Pharmaceuticals names Sujay Kango as Chief Commercial Officer
Subscribe for More Information
April 13, 2015
14:29 EDTYUMYum! Brands volatility increases into Q1 and outlook
Yum! Brands April call option implied volatility is at 37, April weekly is at 41, May is at 28; compared to its 26-week average of 22 according to Track Data, suggesting large price movement into the expected release of Q1 results on April 22.
09:34 EDTCELGActive equity options trading on open
Subscribe for More Information
06:02 EDTYUMYum! Brands implied volatility of 29 at upper end of index
05:09 EDTCELGCelgene to purchase 14.35M shares of Mesoblast stock for A$3.82 per share
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use